{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-094893","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2021-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.134433+00:00","generated_at":"2026-06-30T03:16:23.513236+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Ironwood designates new principal financial officer and principal accounting officer","bullets":["Jason Rickard, SVP COO, designated as principal financial officer effective July 16, 2021.","Ronald Silver, Corporate Controller, designated as principal accounting officer effective July 16, 2021.","Silver receives base salary of $280,000, bonus target 25%, and grant of 20,000 RSUs vesting over 4 years.","No departures; both officers previously held senior roles at Ironwood."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-094893","json":"https://secwatch.observer/filing/0001104659-21-094893.json","markdown":"https://secwatch.observer/filing/0001104659-21-094893.md","text":"https://secwatch.observer/filing/0001104659-21-094893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465921094893/0001104659-21-094893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465921094893/tm2122682d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T03:16:23.513236+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27de3ad60f","claim":"Jason Rickard was appointed as Principal Financial Officer at IRONWOOD PHARMACEUTICALS INC.","evidence_excerpt":"On July 16, 2021, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) designated Jason Rickard, 50, the Company’s Senior Vice President, Chief Operating Officer, as the Company’s principal financial officer, and Ronald Silver, 39, the Company’s Corporate Controller, as the Company’s principal accounting officer, in each case, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465921094893/0001104659-21-094893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"designated"},{"label":"Role","value":"Principal Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"9790a3b658","claim":"Ronald Silver was appointed as Principal Accounting Officer at IRONWOOD PHARMACEUTICALS INC.","evidence_excerpt":"On July 16, 2021, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) designated Jason Rickard, 50, the Company’s Senior Vice President, Chief Operating Officer, as the Company’s principal financial officer, and Ronald Silver, 39, the Company’s Corporate Controller, as the Company’s principal accounting officer, in each case, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465921094893/0001104659-21-094893-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"designated"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}